123 related articles for article (PubMed ID: 18089610)
1. The circulating proangiogenic factors CYR61 (CCN1) and NOV (CCN3) are significantly decreased in placentae and sera of preeclamptic patients.
Gellhaus A; Schmidt M; Dunk C; Lye SJ; Winterhager E
Reprod Sci; 2007 Dec; 14(8 Suppl):46-52. PubMed ID: 18089610
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia.
Gellhaus A; Schmidt M; Dunk C; Lye SJ; Kimmig R; Winterhager E
Mol Hum Reprod; 2006 Jun; 12(6):389-99. PubMed ID: 16675545
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the matricellular proteins CYR61 (CCN1) and NOV (CCN3) by hypoxia-inducible factor-1{alpha} and transforming-growth factor-{beta}3 in the human trophoblast.
Wolf N; Yang W; Dunk CE; Gashaw I; Lye SJ; Ring T; Schmidt M; Winterhager E; Gellhaus A
Endocrinology; 2010 Jun; 151(6):2835-45. PubMed ID: 20237132
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Cyr61 and CTGF in placentas from the late pre-eclamptic pregnancy.
Chen X; Liu Y; Xu X; Chen H
J Perinat Med; 2012 Feb; 40(2):199-200. PubMed ID: 22905356
[TBL] [Abstract][Full Text] [Related]
5. CCN1 (CYR61) and CCN3 (NOV) signaling drives human trophoblast cells into senescence and stimulates migration properties.
Kipkeew F; Kirsch M; Klein D; Wuelling M; Winterhager E; Gellhaus A
Cell Adh Migr; 2016 Mar; 10(1-2):163-78. PubMed ID: 26744771
[TBL] [Abstract][Full Text] [Related]
6. CCN3 Signaling Is Differently Regulated in Placental Diseases Preeclampsia and Abnormally Invasive Placenta.
Duan L; Schimmelmann M; Wu Y; Reisch B; Faas M; Kimmig R; Winterhager E; Köninger A; Gellhaus A
Front Endocrinol (Lausanne); 2020; 11():597549. PubMed ID: 33304321
[TBL] [Abstract][Full Text] [Related]
7. Trophoblast debris extruded from preeclamptic placentae activates endothelial cells: a mechanism by which the placenta communicates with the maternal endothelium.
Shen F; Wei J; Snowise S; DeSousa J; Stone P; Viall C; Chen Q; Chamley L
Placenta; 2014 Oct; 35(10):839-47. PubMed ID: 25096950
[TBL] [Abstract][Full Text] [Related]
8. CYR61 (CCN1) is essential for placental development and vascular integrity.
Mo FE; Muntean AG; Chen CC; Stolz DB; Watkins SC; Lau LF
Mol Cell Biol; 2002 Dec; 22(24):8709-20. PubMed ID: 12446788
[TBL] [Abstract][Full Text] [Related]
9. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer.
Jiang WG; Watkins G; Fodstad O; Douglas-Jones A; Mokbel K; Mansel RE
Endocr Relat Cancer; 2004 Dec; 11(4):781-91. PubMed ID: 15613452
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of survivin, the inhibitor of apoptosis protein correlates with severity of preeclampsia.
Li CF; Gou WL; Li XL; Wang SL; Yang T; Chen Q
Placenta; 2012 Jan; 33(1):47-51. PubMed ID: 22033156
[TBL] [Abstract][Full Text] [Related]
12. Proposal for a unified CCN nomenclature.
Brigstock DR; Goldschmeding R; Katsube KI; Lam SC; Lau LF; Lyons K; Naus C; Perbal B; Riser B; Takigawa M; Yeger H
Mol Pathol; 2003 Apr; 56(2):127-8. PubMed ID: 12665631
[TBL] [Abstract][Full Text] [Related]
13. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.
Lin CG; Chen CC; Leu SJ; Grzeszkiewicz TM; Lau LF
J Biol Chem; 2005 Mar; 280(9):8229-37. PubMed ID: 15611078
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent differential upregulation of CCN1/Cyr61 and CCN3/NOV by the gap junction protein Connexin43 in glioma cells.
Sin WC; Bechberger JF; Rushlow WJ; Naus CC
J Cell Biochem; 2008 Apr; 103(6):1772-82. PubMed ID: 18004727
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas.
Sampath D; Zhu Y; Winneker RC; Zhang Z
J Clin Endocrinol Metab; 2001 Apr; 86(4):1707-15. PubMed ID: 11297607
[TBL] [Abstract][Full Text] [Related]
16. The CCN family: a new stimulus package.
Brigstock DR
J Endocrinol; 2003 Aug; 178(2):169-75. PubMed ID: 12904165
[TBL] [Abstract][Full Text] [Related]
17. Decorin over-expression by decidual cells in preeclampsia: a potential blood biomarker.
Siddiqui MF; Nandi P; Girish GV; Nygard K; Eastabrook G; de Vrijer B; Han VK; Lala PK
Am J Obstet Gynecol; 2016 Sep; 215(3):361.e1-361.e15. PubMed ID: 27001218
[TBL] [Abstract][Full Text] [Related]
18. Mechanical regulation of the Cyr61/CCN1 and CTGF/CCN2 proteins.
Chaqour B; Goppelt-Struebe M
FEBS J; 2006 Aug; 273(16):3639-49. PubMed ID: 16856934
[TBL] [Abstract][Full Text] [Related]
19. A single bout of exercise with high mechanical loading induces the expression of Cyr61/CCN1 and CTGF/CCN2 in human skeletal muscle.
Kivelä R; Kyröläinen H; Selänne H; Komi PV; Kainulainen H; Vihko V
J Appl Physiol (1985); 2007 Oct; 103(4):1395-401. PubMed ID: 17673559
[TBL] [Abstract][Full Text] [Related]
20. Expression of von Hippel Lindau (pVHL) protein in placentae from normal pregnant women and women with preeclampsia.
Rajakumar A; Doty K; Daftary A; Markovic N; Conrad KP
Placenta; 2006; 27(4-5):411-21. PubMed ID: 15955559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
